Catherine A. O'sullivan
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Correction: Real‑World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis.
Journal: Rheumatology and therapy
Published: September 13, 2025
The Relationship Between Patient-Reported Quality of Life and Physician-Derived Clinical Outcomes in Rheumatoid Arthritis in the Australian OPAL Dataset.
Journal: International journal of rheumatic diseases
Published: November 01, 2024
Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis.
Journal: Rheumatology and therapy
Published: October 18, 2024
Propagation, Establishment, and Early Fruit Production of Table Grape Microvines in an LED-Lit Hydroponics System: A Demonstration Case Study.
Journal: Plant-environment interactions (Hoboken, N.J.)
Published: July 31, 2024
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia.
Journal: Clinical rheumatology
Published: November 23, 2023
Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL dataset.
Journal: Clinical and experimental rheumatology
Published: November 06, 2023
Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022.
Journal: Clinical rheumatology
Published: October 31, 2023
Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost-savings.
Journal: Internal medicine journal
Published: October 03, 2023
Last Updated: 09/26/2026